generic (UK) Ltd (T/A Mylan)诉Warner-Lambert Company LLC

{"title":"generic (UK) Ltd (T/A Mylan)诉Warner-Lambert Company LLC","authors":"","doi":"10.1093/rpc/rcz005","DOIUrl":null,"url":null,"abstract":"\n Patents – Swiss-form claims – Pregabalin – Use in the manufacture or preparation of a medicament for the treating of pain – Construction – Validity – Infringement – Meaning of “for treating” neuropathic pain – Whether central neuropathic pain included – Insufficiency – Biogen insufficiency – Plausibility – Whether plausibility required across full width of claim – Nature of the plausibility requirement – Direct infringement under s.60(1)(b) – Whether intention a necessary element – Nature of the infringement test in relation to claims in Swiss form – Manufacturer liability – “Downstream” liability – Whether subjective intention required – Reasonable foreseeability – The role of packaging – Indirect infringement – Amendment – Post-trial validating amendments – Abuse of process – Discretion – Appeal to Supreme Court","PeriodicalId":336842,"journal":{"name":"Reports of Patent, Design and Trade Mark Cases","volume":"3 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2018-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":"{\"title\":\"Generics (UK) Ltd (T/A Mylan) v Warner-Lambert Company LLC\",\"authors\":\"\",\"doi\":\"10.1093/rpc/rcz005\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\\n Patents – Swiss-form claims – Pregabalin – Use in the manufacture or preparation of a medicament for the treating of pain – Construction – Validity – Infringement – Meaning of “for treating” neuropathic pain – Whether central neuropathic pain included – Insufficiency – Biogen insufficiency – Plausibility – Whether plausibility required across full width of claim – Nature of the plausibility requirement – Direct infringement under s.60(1)(b) – Whether intention a necessary element – Nature of the infringement test in relation to claims in Swiss form – Manufacturer liability – “Downstream” liability – Whether subjective intention required – Reasonable foreseeability – The role of packaging – Indirect infringement – Amendment – Post-trial validating amendments – Abuse of process – Discretion – Appeal to Supreme Court\",\"PeriodicalId\":336842,\"journal\":{\"name\":\"Reports of Patent, Design and Trade Mark Cases\",\"volume\":\"3 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2018-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"2\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Reports of Patent, Design and Trade Mark Cases\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1093/rpc/rcz005\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Reports of Patent, Design and Trade Mark Cases","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/rpc/rcz005","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 2

摘要

专利-瑞士形式权利要求-普瑞巴林-用于治疗疼痛的药物的制造或制备-结构-有效性-侵权-“用于治疗”神经性疼痛的含义-是否包括中枢神经性疼痛-功能不全-生物原功能不全-合理性-是否要求在整个权利要求范围内具有合理性-合理性要求的性质-根据第60(1)(b)条的直接侵权-意图是否是必要要素-与瑞士形式索赔有关的侵权检验-制造商责任-“下游”责任-是否需要主观意图-合理的可预见性-包装的作用-间接侵权-修正-审判后确认修正-滥用程序-自由裁量权-向最高法院上诉
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Generics (UK) Ltd (T/A Mylan) v Warner-Lambert Company LLC
Patents – Swiss-form claims – Pregabalin – Use in the manufacture or preparation of a medicament for the treating of pain – Construction – Validity – Infringement – Meaning of “for treating” neuropathic pain – Whether central neuropathic pain included – Insufficiency – Biogen insufficiency – Plausibility – Whether plausibility required across full width of claim – Nature of the plausibility requirement – Direct infringement under s.60(1)(b) – Whether intention a necessary element – Nature of the infringement test in relation to claims in Swiss form – Manufacturer liability – “Downstream” liability – Whether subjective intention required – Reasonable foreseeability – The role of packaging – Indirect infringement – Amendment – Post-trial validating amendments – Abuse of process – Discretion – Appeal to Supreme Court
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信